Yasmin / Yaz Settlement
What is the Status of Yaz and Yasmin Settlements?
Settlement agreements have been reached in thousands of Yaz injury lawsuits and Yasmin injury lawsuits filed by women throughout the United States, and negotiations continue on a case-by-case basis for claims involving blood clots caused by the popular birth control pills.
Bayer has faced two “categories” of cases involving side effects of Yaz, Yasmin, Ocella, Beyaz and other drospirenone-based birth control pills:
- Blood clot injuries, such as pulmonary embolism, deep vein thrombosis and stroke
- Gallbladder disease and gallbladder removal cases
Yaz Blood Clot Settlements
According to Bayer’s 2013 Annual Statement, which was released in February 2014, the drug maker had agreed to pay more than $1.69 billion to resolve an estimated 8,250 lawsuits alleging women suffered a:
- Heart attack or Stroke from Yaz or Yasmin
- Pulmonary Embolism from Yaz or Yasmin
- Deep Vein Thrombosis from Yaz or Yasmin
However, the drug maker still faces more than 4,600 additional claims involving a venous or arterial thromboembolism injury. Bayer is continuing to negotiate venous clot injuries on a case-by-case basis, after complete documentation and presentation of the claim by an attorney.
The process of settling Yaz and Yasmin lawsuits is far from over, and our lawyers are continuing to review and evaluate potential claims for women who suffered a pulmonary embolism, deep vein thrombosis, heart attack, stroke or other blood clot injury while using the popular birth control pills.
To find out if you, a friend or family member may qualify for a Yaz settlement or Yasmin settlement as compensation for injuries caused by the birth control pills, request a free consultation and claim evaluation with our lawyers.
Yaz Gallbladder Settlements
In addition to blood clot lawsuits, Bayer also faces a large number of claims brought by women who have suffered gallbladder disease or a gallbladder injury from Yaz or Yasmin, which often resulted in the need for removal of the gallbladder.
While the lawsuits allege that Bayer failed to adequately warn about the increased risk of gallbladder problems that may be caused by drospirenone, as the litigation has proceeded, plaintiffs have faced an uphill battle establishing that the birth control pills increase the risk of gallbladder injury when compared to other oral birth control pills.
After refusing to consider settling Yaz gallbladder lawsuits, Bayer did agree to a settlement program in March 2013, which does allow plaintiffs who suffered gallbladder injuries to secure recovery, despite negative scientific findings that may have made it difficult to succeed at trial.
Under terms of the agreement, Bayer has agreed to pay $2,000 to women who can establish that they suffered a gallbladder injury and $3,000 to women who required gallbladder removal. However, the total of all settlements the drug maker is willing to pay is capped at $24 million. To participate in the settlement, women must have filed and served their lawsuit before March 25, 2013.
According to information released by Bayer in August 2013, at least 8,800 women have elected to participate in the gallbladder settlement, which means that the minimum participation level of 90% has been met to move forward with the resolution of these claims.
Our lawyers are no longer taking on new claims for users of Yaz or Yasmin, where the only injury involves the gallbladder.